Gri Bio Inc (GRI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -9,297 | -5,938 | -3,046 | -8,207 | -6,259 |
| Depreciation Amortization | 3 | 2 | 1 | 4 | 3 |
| Accounts payable and accrued liabilities | 391 | 371 | 331 | -387 | -147 |
| Other Working Capital | 1,317 | 750 | 1,078 | -448 | -347 |
| Other Operating Activity | 371 | -87 | -100 | 427 | 138 |
| Operating Cash Flow | $-7,215 | $-4,902 | $-1,736 | $-8,611 | $-6,612 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | 0 | N/A | N/A | N/A | 1 |
| Common Stock Issued | 7,560 | 5,941 | N/A | 13,865 | 11,487 |
| Other Financing Activity | -1,318 | -945 | -11 | -2,034 | -1,938 |
| Financing Cash Flow | $6,242 | $4,996 | $-11 | $11,831 | $9,550 |
| Beginning Cash Position | 5,028 | 5,028 | 5,028 | 1,808 | 1,808 |
| End Cash Position | 4,055 | 5,122 | 3,281 | 5,028 | 4,746 |
| Net Cash Flow | $-973 | $94 | $-1,747 | $3,220 | $2,938 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,215 | -4,902 | -1,736 | -8,611 | -6,612 |
| Free Cash Flow | -7,215 | -4,902 | -1,736 | -8,611 | -6,612 |